Spyre Therapeutics, Inc. · NASDAQ:SYRE

Turtle Cameron sold 15,000 Spyre Therapeutics, Inc. shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 3, 2026

On Jun 1, 2026, Turtle Cameron (Director, Chief Executive Officer) sold 15,000 Spyre Therapeutics, Inc. shares at an average US$70.43 for US$1.06M under a trading plan, leaving 597,540 shares. Filed Jun 3, 2026 (Form 4).

Sold
15,000 shares
Price
US$70.43 average (US$69.40 to US$71.38)
Value
US$1.06M
Holding after
597,540 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common StockSale3,557US$69.40608,983Direct
Jun 1, 2026Common StockSale8,149US$70.50600,834Direct
Jun 1, 2026Common StockSale3,294US$71.38597,540Direct

Source

View original at SEC

Related